Antibodies to stem cell marker antigens reduce engraftment of hematopoietic stem cells

Stem Cells

Volumn 25, Issue 2, 2007, Pages 279-288

  Gilner, Jennifer B ^a   Walton, William G ^a   Gush, Kimberly ^a   Kirby, Suzanne L ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Hematopoietic stem cell transplantation; Hematopoietic stem cells; Long term engraftment; Sca 1+c Kit +Lin ; Side population cells

Indexed keywords

ANTIBODY; ATAXIN 1; CD150 ANTIGEN; CD34 ANTIGEN; HOE 33342; STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; CELL POPULATION; CELL SELECTION; CONTROLLED STUDY; ENGRAFTMENT; HEMATOPOIETIC STEM CELL; INCUBATION TIME; MOUSE; NONHUMAN; SEPARATION TECHNIQUE;

ANIMALS; ANTIBODIES; ANTIGENS, DIFFERENTIATION; BENZIMIDAZOLES; CELL CYCLE; CELL SEPARATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-KIT; RNA, MESSENGER; STEM CELLS; WHOLE-BODY IRRADIATION;

MUS;

EID: 33846905976     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0076     Document Type: Article

References (86)

1. Visser JW, Bauman JG, Mulder AH et al. Isolation of murine pluripotent hemopoietic stem cells. J Exp Med 1984;159:1576-1590.
2. Ortiz M, Wine JW, Lohrey N et al. Functional characterization of a novel hematopoietic stem cell and its place in the c-Kit maturation pathway in bone marrow cell development. Immunity 1999;10:173-182.
3. Goodell MA, Brose K, Paradis G et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996;183:1797-1806.
4. Zijlmans JM, Visser JW, Kleiverda K et al. Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability. Proc Natl Acad Sci U S A 1995;92:8901-8905.
5. Hodgson GS, Bradley TR. Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: Evidence for a pre-CFU-S cell? Nature 1979;281:381-382.
6. Lerner C, Harrison DE. 5-Fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp Hematol 1990;18:114 -118.
7. Van Zant G. Studies of hematopoietic stem cells spared by 5-fluorouracil. J Exp Med 1984;159:679-690.
8. Kiefer F, Wagner EF, Keller G. Fractionation of mouse bone marrow by adherence separates primitive hematopoietic stem cells from in vitro colony-forming cells and spleen colony-forming cells. Blood 1991;78:2577-2582.
9. Muller-Sieburg CE, Whitlock CA, Weissman IL. Isolation of two early B lymphocyte progenitors from mouse marrow: A committed pre-pre-B cell and a clonogenic Thy-1-lo hematopoietic stem cell. Cell 1986;44:653-662.
10. Spangrude GJ, Heimfeld S, Weissman IL. Purification and characterization of mouse hematopoietic stem cells. Science 1988;241:58-62.
11. Okada S, Nakauchi H, Nagayoshi K et al. In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. Blood 1992;80:3044-3050.
12. Randall TD, Lund FE, Howard MC et al. Expression of murine CD38 defines a population of long-term reconstituting hematopoietic stem cells. Blood 1996;87:4057-4067.
13. Osawa M, Hanada K, Hamada H et al. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996;273:242-245.
14. Morrison SJ, Wandycz AM, Hemmati HD et al. Identification of a lineage of multipotent hematopoietic progenitors. Development 1997;124:1929-1939.
15. Christensen JL, Weissman IL. Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells. Proc Natl Acad Sci U S A 2001;98:14541-14546.
16. Chen CZ, Li M, de Graaf D et al. Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells. Proc Natl Acad Sci U S A 2002;99:15468-15473.
17. Cheng J, Baumhueter S, Cacalano G et al. Hematopoietic defects in mice lacking the sialomucin CD34. Blood 1996;87:479-490.
18. Stanford WL, Haque S, Alexander R et al. Altered proliferative response by T lymphocytes of Ly-6A (Sca-1) null mice. J Exp Med 1997;186:705-717.
19. Waskow C, Paul S, Haller C et al. Viable c-Kit(W/W) mutants reveal pivotal role for c-kit in the maintenance of lymphopoiesis. Immunity 2002;17:277-288.
20. Waskow C, Terszowski G, Costa C et al. Rescue of lethal c-KitW/W mice by erythropoietin. Blood 2004;104:1688-1695.
21. Morrison SJ, Wandycz AM, Akashi K et al. The aging of hematopoietic stem cells. Nat Med 1996;2:1011-1016.
22. Spangrude GJ, Brooks DM, Tumas DB. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: In vivo expansion of stem cell phenotype but not function. Blood 1995;85:1006-1016.
23. Basson MA, Bommhardt U, Mee PJ et al. Molecular requirements for lineage commitment in the thymus-antibody-mediated receptor engagements reveal a central role for lck in lineage decisions. Immunol Rev 1998;165:181-194.
24. Kroesen BJ, Bakker A, van Lier RA et al. Bispecific antibody-mediated target cell-specific costimulation of resting T cells via CD5 and CD28. Cancer Res 1995;55:4409-4415.
25. Ludwig DL, Pereira DS, Zhu Z et al. Monoclonal antibody therapeutics and apoptosis. Oncogene 2003;22:9097-9106.
26. Rubio G, Ferez X, Sanchez-Campillo M et al. Cross-linking of MHC class I molecules on human NK cells inhibits NK cell function, segregates MHC I from the NK cell synapse, and induces intracellular phosphotyrosines. J Leukoc Biol 2004;76:116-124.
27. Saouaf SJ, Mahajan S, Rowley RB et al. Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement. Proc Natl Acad Sci U S A 1994;91:9524 -9528.
28. Schlitt HJ, Schwinzer R, Wonigeit K. Different activation states of human lymphocytes after antibody-mediated stimulation via CD3 and the alpha/beta T-cell receptor. Scand J Immunol 1990;32:717-726.
29. Schneider H, Chaovapong W, Matthews DJ et al. Homodimerization of erythropoietin receptor by a bivalent monoclonal antibody triggers cell proliferation and differentiation of erythroid precursors. Blood 1997;89:473-482.
30. Steff AM, Fortin M, Philippoussis F et al. A cell death pathway induced by antibody-mediated cross-linking of CD45 on lymphocytes. Crit Rev Immunol 2003;23:421-440.
31. Veillette A, Bolen JB, Bookman MA. Alterations in tyrosine protein phosphorylation induced by antibody-mediated cross-linking of the CD4 receptor of T lymphocytes. Mol Cell Biol 1989;9:4441-4446.
32. Rowan WC, Hale G, Tite JP et al. Cross-linking of the CAMPATH-1 antigen (CD52) triggers activation of normal human T lymphocytes. Int Immunol 1995;7:69-77.
33. Marmor MD, Bachmann MF, Ohashi PS et al. Immobilization of glycosylphosphatidylinositol-anchored proteins inhibits T cell growth but not function. Int Immunol 1999;11:1381-1393.
34. Lambert JF, Liu M, Colvin GA et al. Marrow stem cells shift gene expression and engraftment phenotype with cell cycle transit. J Exp Med 2003;197:1563-1572.
35. Ikawa M, Kominami K, Yoshimura Y et al. A rapid and non-invasive selection of transgenic embryos before implantation using green fluorescent protein (GFP). FEBS Lett 1995;375:125-128.
36. Dubois NA, Kolpack LC, Wang R et al. Isolation and characterization of an established endothelial cell line from transgenic mouse hemangiomas. Exp Cell Res 1991;196:302-313.
37. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408.
38. Shivdasani RA, Orkin SH. The transcriptional control of hematopoiesis. Blood 1996;87:4025-4039.
39. Cosman D. The hematopoietin receptor superfamily. Cytokine 1993;5:95-106.
40. Chabot B, Stephenson DA, Chapman VM et al. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 1988;335:88-89.
41. Terman BI, Dougher-Vermazen M, Carrion ME et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992;187:1579-1586.
42. Dumont DJ, Gradwohl GJ, Fong GH et al. The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors. Oncogene 1993;8:1293-1301.
43. Newman PJ, Berndt MC, Gorski J et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990;247:1219-1222.
44. Sherr CJ, Rettenmier CW, Sacca R et al. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 1985;41:665-676.
45. Yam LT, Li CY, Crosby WH. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 1971;55:283-290.
46. Tilghman SM, Tiemeier DC, Polsky F et al. Cloning specific segments of the mammalian genome: Bacteriophage lambda containing mouse globin and surrounding gene sequences. Proc Natl Acad Sci U S A 1977;74:4406-4410.
47. Mohle R, Bautz F, Rafii S et al. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 1998;91:4523-4530.
48. Durig J, de Wynter EA, Kasper C et al. Expression of macrophage inflammatory protein-1 receptors in human CD34(+) hematopoietic cells and their modulation by tumor necrosis factor-alpha and interferongamma. Blood 1998;92:3073-3081.
49. Nakauchi H, Takano H, Ema H et al. Further characterization of CD34-low/negative mouse hematopoietic stem cells. Ann N Y Acad Sci 1999;872:57- 66; discussion 66-70.
50. Haneline LS, Broxmeyer HE, Cooper S et al. Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac-/- mice. Blood 1998;91:4092-4098.
51. Peled A, Petit I, Kollet O et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999;283:845-848.
52. Mar L, Hoodless PA. Embryonic fibroblasts from mice lacking Tgif were defective in cell cycling. Mol Cell Biol 2006;26:4302-4310.
53. Evans T. Regulation of hematopoiesis by retinoid signaling. Exp Hematol 2005;33:1055-1061.
54. Wotton D, Knoepfler PS, Laherty CD et al. The Smad transcriptional corepressor TGIF recruits mSin3. Cell Growth Differ 2001;12:457-463.
55. Corbel C, Salaun J. AlphaIIb integrin expression during development of the murine hemopoietic system. Dev Biol 2002;243:301-311.
56. Liu Y, Snow BE, Hande MP et al. The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr Biol 2000;10:1459-1462.
57. Zhou S, Morris JJ, Barnes Y et al. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc Natl Acad Sci U S A 2002;99:12339-12344.
58. Ito CY, Li CY, Bernstein A et al. Hematopoietic stem cell and progenitor defects in Sca-1/Ly-6A-null mice. Blood 2003;101:517-523.
59. Dunlop DJ, Wright EG, Lorimore S et al. Demonstration of stem cell inhibition and myeloprotective effects of SCI/rhMIP1 alpha in vivo. Blood 1992;79:2221-2225.
60. Graham GJ, Wright EG, Hewick R et al. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature 1990;344:442-444.
61. Lord BI, Dexter TM, Clements JM et al. Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo. Blood 1992;79:2605-2609.
62. Honczarenko M, Le Y, Glodek AM et al. CCR5-binding chemokines modulate CXCL12 (SDF-1)-induced responses of progenitor B cells in human bone marrow through heterologous desensitization of the CXCR4 chemokine receptor. Blood 2002;100:2321-2329.
63. Okada S, Nakauchi H, Nagayoshi K et al. Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood 1991;78:1706-1712.
64. Kiel MJ, Yilmaz OH, Iwashita T et al. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005;121:1109-1121.
65. Orschell-Traycoff CM, Hiatt K, Dagher RN et al. Homing and engraftment potential of Sca-1(+)lin(-) cells fractionated on the basis of adhesion molecule expression and position in cell cycle. Blood 2000;96:1380-1387.
66. Fleming WH, Alpern EJ, Uchida N et al. Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol 1993;122:897-902.
67. Szilvassy SJ, Bass MJ, Van Zant G et al. Organ-selective homing defines engraftment kinetics of murine hematopoietic stem cells and is compromised by ex vivo expansion. Blood 1999;93:1557-1566.
68. Traycoff CM, Cornetta K, Yoder MC et al. Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential. Exp Hematol 1996;24:299-306.
69. Cheng T, Rodrigues N, Shen H et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 2000;287:1804-1808.
70. Passegue E, Wagers AJ, Giuriato S et al. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med 2005;202:1599-1611.
71. Wagers AJ, Weissman IL. Differential expression of alpha2 integrin separates long-term and short-term reconstituting Lin-/loThy1.1(lo)c-kit+ Sca-1+ hematopoietic stem cells. STEM CELLS 2006;24:1087-1094.
72. Liu Y, Martindale JL, Gorospe M et al. Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res 1996;56:31-35.
73. Macleod KF, Sherry N, Hannon G et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 1995;9:935-944.
74. Mantel C, Luo Z, Canfield J et al. Involvement of p21cip-1 and p27kip-1 in the molecular mechanisms of steel factor-induced proliferative synergy in vitro and of p21cip-1 in the maintenance of stem/progenitor cells in vivo. Blood 1996;88:3710-3719.
75. Lee A, Kessler JD, Read TA et al. Isolation of neural stem cells from the postnatal cerebellum. Nat Neurosci 2005;8:723-729.
76. Rietze RL, Valcanis H, Brooker GF et al. Purification of a pluripotent neural stem cell from the adult mouse brain. Nature 2001;412:736 -739.
77. Uchida N, Buck DW, He D et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 2000;97:14720-14725.
78. Boquest AC, Shahdadfar A, Fronsdal K et al. Isolation and transcription profiling of purified uncultured human stromal stem cells: Alteration of gene expression after in vitro cell culture. Mol Biol Cell 2005;16:1131-1141.
79. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964 -967.
80. Salven P, Mustjoki S, Alitalo R et al. VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood 2003;101:168-172.
81. Montarras D, Morgan J, Collins C et al. Direct isolation of satellite cells for skeletal muscle regeneration. Science 2005;309:2064-2067.
82. Stamp L, Crosby HA, Hawes SM et al. A novel cell-surface marker found on human embryonic hepatoblasts and a subpopulation of hepatic biliary epithelial cells. STEM CELLS 2005;23:103-112.
83. Tanimizu N, Nishikawa M, Saito H et al. Isolation of hepatoblasts based on the expression of Dlk/Pref-1. J Cell Sci 2003;116:1775-1786.
84. Challen GA, Little MH. A side order of stem cells: The SP phenotype. STEM CELLS 2006;24:3-12.
85. Smith LG, Weissman IL, Heimfeld S. Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc Natl Acad Sci U S A 1991;88:2788-2792.
86. -) hemopoietic stem cells. J Immunol 1996;156:3207-3214.